Finance

Lists
Why is RMTI down 2,54%?
Dive Deeper
RMTI:NASDAQ
Rockwell Medical Ord Shs
8,43 US$
-2,54%
(-0,22) 1D
5 ოქტ, 13:19:45 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RMTI...
Open
8,50 US$
High
8,50 US$
Low
8,39 US$
Mkt. cap
33,98 მლნ.
Avg. vol.
21,32 ათ.
Volume
4,25 ათ.
52-wk high
12,90 US$
52-wk low
4,88 US$
EPS
-1,37 US$
Beta
1,63
Shares outstanding
4,03 მლნ.
No. of employees
157
Open
8,50 US$
High
8,50 US$
Low
8,39 US$
Mkt. cap
33,98 მლნ.
Avg. vol.
21,32 ათ.
Volume
4,25 ათ.
52-wk high
12,90 US$
52-wk low
4,88 US$
EPS
-1,37 US$
Beta
1,63
Shares outstanding
4,03 მლნ.
No. of employees
157
News stories
From web sources and news partners
Profile
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease. The company's primary customers are dialysis providers. Wikipedia
About Rockwell Medical Ord Shs
CEO-
Employees157
Founded1996
HeadquartersWixom, მიჩიგანის შტატი, ამერიკის შეერთებული შტატები
SectorMedical device
Analyst ratings
Based on 2 analysts giving stock ratings to RMTI in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for RMTI in the last 3 months.
Highest
Current 8,43 US$
20,00 US$ (+137,25%)
Average
20,00 US$ (+137,25%)
Lowest
20,00 US$ (+137,25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
20,00 US$
+137,2%
09/11/2026
Anthony Vendetti
Maxim Group
Buy
Maintained
20,00 US$
+137,2%
08/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
15,93 მლნ.
18,35 მლნ.
17,34 მლნ.
17,78 მლნ.
Cost of goods sold
13,66 მლნ.
14,47 მლნ.
14,44 მლნ.
14,54 მლნ.
Cost of revenue
13,66 მლნ.
14,47 მლნ.
14,44 მლნ.
14,54 მლნ.
Research and development expenses
-
-
-
40,00 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,86 მლნ.
4,28 მლნ.
4,38 მლნ.
4,26 მლნ.
Operating expense
3,86 მლნ.
4,28 მლნ.
4,38 მლნ.
4,30 მლნ.
Total operating expenses
17,51 მლნ.
18,74 მლნ.
18,82 მლნ.
18,84 მლნ.
Operating income
-1,58 მლნ.
-398,00 ათ.
-1,48 მლნ.
-1,06 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-1,75 მლნ.
-554,00 ათ.
-1,60 მლნ.
-1,17 მლნ.
EBT excluding unusual items
-1,81 მლნ.
-640,00 ათ.
-1,72 მლნ.
-1,30 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,75 მლნ.
-554,00 ათ.
-1,60 მლნ.
-1,17 მლნ.
Net profit margin
-11,01%
-3,02%
-9,26%
-6,59%
Earnings per share
-
-
-
-
Interest and investment income
55,00 ათ.
44,00 ათ.
37,00 ათ.
40,00 ათ.
Interest expense
-285,00 ათ.
-286,00 ათ.
-282,00 ათ.
-281,00 ათ.
Net interest expenses
-230,00 ათ.
-242,00 ათ.
-245,00 ათ.
-241,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,04 მლნ.
148,00 ათ.
-969,00 ათ.
-569,00 ათ.
Gain or loss from assets sale
-1,00 ათ.
1,00 ათ.
178,00 ათ.
-32,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები